-

Company Profile for Pharmaceutical Strategies Group

--(BUSINESS WIRE)--For more than 25 years, PSG has been relentlessly advocating for our clients as they navigate the complex and ever-changing challenges of drug cost management. Our innovative drug management solutions, including our proprietary data and analytics platform, Artemetrx, deliver actionable insights with exceptional financial and clinical value. We function as a strategic partner through our industry-leading intelligence and technologies to realize billions of dollars in drug cost savings for our clients every year.

Company:

 

Pharmaceutical Strategies Group

 

 

 

Headquarters Address:

 

5360 Legacy Drive | Building 3, Ste 230

 

 

Plano, TX 75024

 

 

 

Main Telephone:

 

+1 469-974-6152

 

 

 

Website:

 

psgconsults.com

 

 

 

Type of Organization:

 

Private

 

 

 

Industry:

 

Pharmaceutical

 

 

 

Key Executives:

 

CEO: Dave Borden

 

 

President: Michael Lonergan

 

 

 

Public Relations

 

 

Contact:

 

Samantha Rideout

Phone:

 

+1 469-974-6152

Email:

 

srideout@psgconsults.com

 

Industry:

Pharmaceutical Strategies Group

Release Versions
English
Social Media Profiles
PSG on LinkedIn
More News From Pharmaceutical Strategies Group

PSG Announces Results of Highly Comprehensive Pharmacy Benefit Manager Survey

DALLAS--(BUSINESS WIRE)--Pharmaceutical Strategies Group (PSG), an EPIC company, has released its 25th annual 2022 Pharmacy Benefit Manager Customer Satisfaction Report. This extensive report represents the most comprehensive satisfaction research survey in the pharmacy benefit manager (PBM) space, providing unparalleled data and insights. PBM satisfaction rankings in 2022 There was a notable downturn in overall satisfaction levels, as well as in some core measures of general satisfaction such...

PSG Announces New Features Designed to Support Biosimilar Strategy

DALLAS & SAN FRANCISCO--(BUSINESS WIRE)--Pharmaceutical Strategies Group (PSG), an EPIC company, announced an enhancement of its data and analytics platform, Artemetrx®, which will significantly enhance clients’ ability to track and report on the adoption of biosimilar medications. Artemetrx is the leading integrated pharmacy and medical claims platform and is utilized by health plans, pharmacy benefit managers, and employers for drug cost management. While biosimilars have been available in th...

Proprietary State of Specialty Spend and Trend Report Released by Pharmaceutical Strategies Group

DALLAS--(BUSINESS WIRE)--The Artemetrx Specialty Spend and Trend Report, by PSG, shows biosimilar adoption, but double-digit specialty drug trend persists....
Back to Newsroom